MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Suggest Documents
Menopausal hormone therapy and menopausal symptoms.
Menopausal Hormone Therapy and Chronic Disease Risk in the Women's Health Initiative: Is Timing Everything?
Progestogens in menopausal hormone therapy.
Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
Menopausal hormone therapy and venous thromboembolism.
Extended duration use of menopausal hormone therapy.
Menopausal hormone replacement therapy in dermatology.
Myocardial infarction, atrial fibrillation and mortality: timing is everything.
Menopausal hormone therapy and quality of life: too many pyjamas.
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
Thrombolytic therapy in myocardial infarction.
Growth hormone for risk stratification and effects of therapy in acute myocardial infarction.
Cell therapy for myocardial infarction.
Fibrinolytic therapy in myocardial infarction.
Effects of menopausal hormone therapy on uterine myoma in menopausal women.
Optimizing thrombolytic therapy of acute myocardial infarction.
Ultra-low dose - new approaches in menopausal hormone therapy.
Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Introduction: menopausal hormone therapy: where are we today?
Prescribing menopausal hormone therapy: an evidence-based approach.
Reproductive endocrinology: Menopausal hormone therapy-ovarian cancer risk revisited.
Thrombolytic therapy in suspected myocardial infarction.
Incidence and timing of serious arrhythmias after early revascularization in non ST-elevation myocardial infarction.
Electrocardiography in pericarditis and ST-elevation myocardial infarction: timing of observation is critical.
Timing of menopausal hormone therapy and myocardial infarction.
Timing of menopausal hormone therapy and myocardial infarction. - PDF Download Free
1KB Sizes
0 Downloads
7 Views
Download PDF
Recommend Documents
Menopausal hormone therapy and menopausal symptoms.
Menopausal Hormone Therapy and Chronic Disease Risk in the Women's Health Initiative: Is Timing Everything?
Progestogens in menopausal hormone therapy.
Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
Menopausal hormone therapy and venous thromboembolism.
Extended duration use of menopausal hormone therapy.
Menopausal hormone replacement therapy in dermatology.
Myocardial infarction, atrial fibrillation and mortality: timing is everything.
Menopausal hormone therapy and quality of life: too many pyjamas.
The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms